All posts by Elaine Huesing

Editor Publisher, HIM&CC

Geneseeq and AstraZeneca Collaborate to Build Guangzhou Bio-Diagnostics Innovation Center

TORONTO, April 27, 2021 /CNW/ – Geneseeq Technology Inc. (“Geneseeq”), a precision oncology diagnostics company, and AstraZeneca (LSE: AZN) (STO: AZN) (Nasdaq: AZN), a global biopharmaceutical company, are excited to announce their strategic collaboration to establish a Bio-Diagnostic Innovation Center in Guangzhou, China. The center is expected to initiate an integrative and patient-centric program where disease diagnosis, treatment, and … Continue reading Geneseeq and AstraZeneca Collaborate to Build Guangzhou Bio-Diagnostics Innovation Center

Stevenson Memorial Hospital to Deploy Novari ATC System

KINGSTON, ON – Novari Health has announced that it has executed an agreement with Stevenson Memorial Hospital to immediately implement its surgical wait list management and eBooking technology. The Novari ATC software is being implemented at Stevenson Memorial Hospital.  The technology is being provided as software as a service (SaaS) to the hospital and all surgical offices.  The system will provide these surgeons and their … Continue reading Stevenson Memorial Hospital to Deploy Novari ATC System

Genome Canada Goes Live with National Data Portal to Track COVID-19 in Real Time

Genome Canada launched the Canadian VirusSeq Data Portal today to track the evolving COVID-19 pandemic across Canada. Now live, the portal is a much-anticipated pillar in the national data infrastructure that will bolster Canada’s ability to manage the current pandemic—and any future ones—by sharing and resourcing viral genome sequences. This made-in-Canada data solution is one of the key … Continue reading Genome Canada Goes Live with National Data Portal to Track COVID-19 in Real Time

NervGen Pharma Announces Appointment of Pharma Veteran Dr. Daniel Mikol as Chief Medical Officer

Vancouver, Canada. April 22, 2021 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, is pleased to announce the appointment of Daniel Mikol, MD, PhD, as the Company’s Chief Medical Officer, effective May 5th, 2021. Dr. Mikol, who … Continue reading NervGen Pharma Announces Appointment of Pharma Veteran Dr. Daniel Mikol as Chief Medical Officer

Great minds think alike: Intel and MILA join forces to put Artificial Intelligence to Work in Medical Research

MONTRÉAL, April 21, 2021 /CNW Telbec/ – Intel Corporation (Nasdaq: INTC) announced a new strategic partnership with Montreal-based MILA (Institut Québécois d’Intelligence Artificielle/Quebec Artificial Intelligence Institute), the world’s largest academic machine learning research institute, which will enable them to develop and apply advances in artificial intelligence (AI). Today’s announcement will lead to collaboration between their respective organizations. Their first … Continue reading Great minds think alike: Intel and MILA join forces to put Artificial Intelligence to Work in Medical Research

Page 3 of 35
1 2 3 4 5 35